Literature DB >> 31784367

Ethical implications of recruiting universal stool donors for faecal microbiota transplantation.

Moiz Mikail1, Kieran C O'Doherty2, Susan M Poutanen3, Susy S Hota4.   

Abstract

Faecal microbiota transplantation is an effective therapy for recurrent Clostridioides difficile infection, with potential therapeutic applications in other health conditions. As research uncovers potential associations between the intestinal microbiome and various disease states, stool donor screening has become increasingly stringent, leading to low donor acceptance. Many stool banks have opted to recruit universal stool donors, who are encouraged to donate frequently over a prolonged period and whose stool is used to treat multiple patients. However, various ethical concerns arise when recruiting universal stool donors, which need to be addressed to mitigate harm to donors. In this Personal View, we describe the major ethical issues with universal stool banks across six domains: informed consent, privacy, the imposing of restrictions on autonomy, stewardship of microbiome information, financial incentives, and preventing a sense of obligation. We also suggest several priorities for future research that should be pursued to address these crucial issues and develop more donor-centric stool banks.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31784367     DOI: 10.1016/S1473-3099(19)30569-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  3 in total

1.  A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.

Authors:  Jianquan He; Xingxiang He; Yonghui Ma; Luxi Yang; Haiming Fang; Shu Shang; Huping Xia; Guanghui Lian; Hailing Tang; Qizhi Wang; Junping Wang; Zhihui Lin; Jianbo Wen; Yuedong Liu; Chunbao Zhai; Wen Wang; Xueliang Jiang; Ji Xuan; Morong Liu; Shiyun Lu; Xuejun Li; Han Wang; Cong Ouyang; Man Cao; Aiqiang Lin; Bangzhou Zhang; Depei Wu; Ye Chen; Chuanxing Xiao
Journal:  Microb Cell Fact       Date:  2021-11-27       Impact factor: 5.328

Review 2.  Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review.

Authors:  Yanghua Liu; Kal Alnababtah; Simon Cook; Ying Yu
Journal:  Therap Adv Gastroenterol       Date:  2021-09-20       Impact factor: 4.409

3.  Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients.

Authors:  Jillian C Thompson; Yi Ren; Kristi Romero; Meagan Lew; Amy T Bush; Julia A Messina; Sin-Ho Jung; Sharareh Siamakpour-Reihani; Julie Miller; Robert R Jenq; Jonathan U Peled; Marcel R M van den Brink; Nelson J Chao; Mark G Shrime; Anthony D Sung
Journal:  PLoS One       Date:  2022-05-04       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.